Johnson Jeremy L, O'Neal Katherine S, Pack Christopher C, Carter Sandra M
1 Southwestern Oklahoma State University College of Pharmacy, Weatherford, OSU Physicians Department of Internal Medicine, Tulsa, OK, USA.
2 University of Oklahoma College of Pharmacy, Tulsa, OK, USA.
J Diabetes Sci Technol. 2017 May;11(3):553-557. doi: 10.1177/1932296816678427. Epub 2016 Nov 15.
An important factor in controlling diabetes is self-monitoring of blood glucose. Manufacturers of glucose meters recommend routine use of control solution to ensure accuracy. Previous studies have demonstrated that glucose meters vary in accuracy and that patients are not using control solution as recommended. The purpose of this study is to identify potential barriers to control solution use from multiple perspectives including patient, pharmacist, and provider.
This study was a prospective, observational survey design. First, 25 randomly selected chain and independent pharmacies in the Tulsa metropolitan area were audited for control solution accessibility. These pharmacies were then used to survey pharmacists, via telephone, regarding control solution inventory and perception of importance of use. Next, providers were electronically surveyed on their routine practice recommendations, while 60 patients with diabetes were randomly selected for telephone survey on use and perceptions of control solution.
Twenty-five pharmacies were audited and 23 pharmacists, 60 patients, and 29 providers were surveyed. Only 39% of pharmacies stated they supplied control solution, however, only 1 pharmacy visibly stocked it. The only patient factor that appeared to have an impact on control solution usage was having type 1 versus type 2 diabetes (38% vs 15%). Providers are aware of what control solution is (62%), but only half felt it should be routine practice with 44% of those never recommending it.
This study raises awareness for the need to educate patients, providers, and pharmacists about use of control solution to ensure glucose meter accuracy.
血糖自我监测是控制糖尿病的一个重要因素。血糖仪制造商建议定期使用质控液以确保准确性。先前的研究表明,血糖仪的准确性存在差异,且患者未按推荐使用质控液。本研究的目的是从患者、药剂师和医疗服务提供者等多个角度识别使用质控液的潜在障碍。
本研究采用前瞻性观察性调查设计。首先,对塔尔萨市区随机选取的25家连锁药店和独立药店进行质控液可及性审核。然后通过电话就质控液库存及对使用重要性的认知对这些药店的药剂师进行调查。接下来,对医疗服务提供者进行关于其常规实践建议的电子调查,同时随机选取60名糖尿病患者进行关于质控液使用及认知的电话调查。
对25家药店进行了审核,对23名药剂师、60名患者和29名医疗服务提供者进行了调查。只有39%的药店表示提供质控液,然而,只有1家药店有明显的库存。唯一似乎对质控液使用有影响的患者因素是患有1型糖尿病与2型糖尿病(38%对15%)。医疗服务提供者知道什么是质控液(62%),但只有一半的人认为应将其作为常规做法,其中44%的人从未推荐过。
本研究提高了人们对有必要对患者、医疗服务提供者和药剂师进行关于使用质控液以确保血糖仪准确性的教育的认识。